Show simple item record

dc.contributor.authorDrinkwater, Nyssaen_US
dc.contributor.authorVu, Hoanen_US
dc.contributor.authorLovell, Kimberly M.en_US
dc.contributor.authorCriscione, Kevin R.en_US
dc.contributor.authorCollins, Brett M.en_US
dc.contributor.authorPrisinzano, Thomas E.en_US
dc.contributor.authorPoulsen, Sally-Annen_US
dc.contributor.authorMcLeish, Michael J.en_US
dc.contributor.authorGrunewald, Gary L.en_US
dc.contributor.authorMartin, Jennifer L.en_US
dc.date.accessioned2017-05-03T11:45:35Z
dc.date.available2017-05-03T11:45:35Z
dc.date.issued2010en_US
dc.date.modified2011-02-14T09:13:09Z
dc.identifier.issn02646021en_US
dc.identifier.doi10.1042/BJ20100651en_AU
dc.identifier.urihttp://hdl.handle.net/10072/36145
dc.description.abstractCNS (central nervous system) adrenaline (epinephrine) is implicated in a wide range of physiol. and pathol. conditions. PNMT (phenylethanolamine N-methyltransferase) catalyzes the final step in the biosynthesis of adrenaline, the conversion of noradrenaline (norepinephrine) to adrenaline by methylation. To help elucidate the role of CNS adrenaline, and to develop potential drug leads, potent, selective and CNS-active inhibitors are required. The fragment screening approach has advantages over other lead discovery methods including high hit rates, more efficient hits and the ability to sample chem. diversity more easily. In the present study we applied fragment-based screening approaches to the enzyme PNMT. We used crystallog. as the primary screen and identified 12 hits from a small com. library of 384 drug-like fragments. The hits include nine chems. with two fused rings and three single-ring chem. systems. Eight of the hits come from three chem. classes: benzimidazoles (a known class of PNMT inhibitor), purines and quinolines. Nine of the hits have measurable binding affinities (.apprx.5-700 .mu.M) as detd. by isothermal titrn. calorimetry and all nine have ligand efficiencies of 0.39 kcal/mol per heavy atom or better (1 kcal4.184 kJ). We synthesized five elaborated benzimidazole compds. and characterized their binding to PNMT, showing for the first time how this class of inhibitors interact with the noradrenaline-binding site. Finally, we performed a pilot study with PNMT for fragment-based screening by MS showing that this approach could be used as a fast and efficient first-pass screening method prior to characterization of binding mode and affinity of hits.en_US
dc.description.peerreviewedYesen_US
dc.description.publicationstatusYesen_AU
dc.languageEnglishen_US
dc.language.isoen_AU
dc.publisherPortland Press Ltden_US
dc.publisher.placeUnited Kingdomen_US
dc.relation.ispartofstudentpublicationNen_AU
dc.relation.ispartofpagefrom51en_US
dc.relation.ispartofpageto61en_US
dc.relation.ispartofissue1en_US
dc.relation.ispartofjournalBiochemical Journalen_US
dc.relation.ispartofvolume431en_US
dc.rights.retentionYen_AU
dc.subject.fieldofresearchMedicinal and Biomolecular Chemistry not elsewhere classifieden_US
dc.subject.fieldofresearchcode030499en_US
dc.titleFragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitorsen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Peer Reviewed (HERDC)en_US
dc.type.codeC - Journal Articlesen_US
gro.date.issued2010
gro.hasfulltextNo Full Text


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record